Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Upgrades
Maxim Group upgraded the previous rating for TOP Ships Inc (NASDAQ:TOPS) from Hold to Buy. NoneThe stock has a 52-week-high of $32.80 and a 52-week-low of $0.75. At the end of the last trading period, TOP Ships closed at $0.78.
According to Needham, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from Hold to Buy. BioCryst Pharmaceuticals earned $0.38 in the fourth quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $19.30 and a 52-week-low of $7.61. At the end of the last trading period, BioCryst Pharmaceuticals closed at $8.64.
For Masimo Corp (NASDAQ:MASI), Raymond James upgraded the previous rating of Market Perform to Outperform. Masimo earned $1.00 in the third quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $176.42 and a 52-week-low of $108.89. At the end of the last trading period, Masimo closed at $160.89.
According to Wolfe Research, the prior rating for Merck & Co Inc (NYSE:MRK) was changed from Peer Perform to Outperform. Merck & Co earned $1.62 in the fourth quarter, compared to $1.80 in the year-ago quarter. At the moment, the stock has a 52-week-high of $115.49 and a 52-week-low of $72.88. Merck & Co closed at $109.07 at the end of the last trading period.
For Shopify Inc (NYSE:SHOP), DA Davidson upgraded the previous rating of Neutral to Buy. For the fourth quarter, Shopify had an EPS of $0.07, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $780.00 and a 52-week-low of $23.63. Shopify closed at $41.42 at the end of the last trading period.
For Alcoa Corp (NYSE:AA), Citigroup upgraded the previous rating of Neutral to Buy. Alcoa earned $0.70 in the fourth quarter, compared to $2.50 in the year-ago quarter. The stock has a 52-week-high of $98.09 and a 52-week-low of $33.55. At the end of the last trading period, Alcoa closed at $48.07.
Keybanc upgraded the previous rating for Nordson Corp (NASDAQ:NDSN) from Sector Weight to Overweight. In the first quarter, Nordson showed an EPS of $1.95, compared to $2.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $251.26 and a 52-week-low of $194.89. Nordson closed at $211.91 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
Vertical Research downgraded the previous rating for Huntsman Corp (NYSE:HUN) from Buy to Hold. In the fourth quarter, Huntsman showed an EPS of $0.04, compared to $0.95 from the year-ago quarter. The current stock performance of Huntsman shows a 52-week-high of $41.65 and a 52-week-low of $23.54. Moreover, at the end of the last trading period, the closing price was at $28.84.
According to Oppenheimer, the prior rating for Biomarin Pharmaceutical Inc (NASDAQ:BMRN) was changed from Outperform to Perform. Biomarin Pharmaceutical earned $0.04 in the third quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $117.77 and a 52-week-low of $70.73. At the end of the last trading period, Biomarin Pharmaceutical closed at $105.97.
For The Hackett Group Inc (NASDAQ:HCKT), Craig-Hallum downgraded the previous rating of Buy to Hold. The Hackett Group earned $0.36 in the fourth quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $24.78 and a 52-week-low of $16.92. At the end of the last trading period, The Hackett Group closed at $21.25.
For Constellation Energy Corp (NASDAQ:CEG), Credit Suisse downgraded the previous rating of Outperform to Neutral. At the moment, the stock has a 52-week-high of $97.89 and a 52-week-low of $42.18. Constellation Energy closed at $80.37 at the end of the last trading period.
According to BTIG, the prior rating for LGI Homes Inc (NASDAQ:LGIH) was changed from Neutral to Sell. LGI Homes earned $1.45 in the fourth quarter, compared to $4.53 in the year-ago quarter. The stock has a 52-week-high of $134.05 and a 52-week-low of $71.73. At the end of the last trading period, LGI Homes closed at $104.66.
According to Northcoast Research, the prior rating for Texas Roadhouse Inc (NASDAQ:TXRH) was changed from Buy to Neutral. In the fourth quarter, Texas Roadhouse showed an EPS of $0.89, compared to $0.76 from the year-ago quarter. The current stock performance of Texas Roadhouse shows a 52-week-high of $107.31 and a 52-week-low of $68.58. Moreover, at the end of the last trading period, the closing price was at $104.58.
Rosenblatt downgraded the previous rating for Sirius XM Holdings Inc (NASDAQ:SIRI) from Buy to Neutral. For the fourth quarter, Sirius XM Holdings had an EPS of $0.09, compared to year-ago quarter EPS of $0.08. The current stock performance of Sirius XM Holdings shows a 52-week-high of $6.85 and a 52-week-low of $4.45. Moreover, at the end of the last trading period, the closing price was at $4.45.
For ACM Research Inc (NASDAQ:ACMR), Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. For the third quarter, ACM Research had an EPS of $0.42, compared to year-ago quarter EPS of $0.19. The current stock performance of ACM Research shows a 52-week-high of $83.79 and a 52-week-low of $5.46. Moreover, at the end of the last trading period, the closing price was at $12.11.
Truist Securities downgraded the previous rating for Interface Inc (NASDAQ:TILE) from Buy to Hold. For the third quarter, Interface had an EPS of $0.30, compared to year-ago quarter EPS of $0.29. The stock has a 52-week-high of $15.05 and a 52-week-low of $8.90. At the end of the last trading period, Interface closed at $11.14.
Evercore ISI Group downgraded the previous rating for Occidental Petroleum Corp (NYSE:OXY) from In-Line to Underperform. For the third quarter, Occidental Petroleum had an EPS of $2.44, compared to year-ago quarter EPS of $0.87. The current stock performance of Occidental Petroleum shows a 52-week-high of $77.13 and a 52-week-low of $37.55. Moreover, at the end of the last trading period, the closing price was at $59.82.
For Industrias Bachoco SAB de CV (NYSE:IBA), JP Morgan downgraded the previous rating of Overweight to Neutral. In the fourth quarter, Industrias Bachoco SAB showed an EPS of $0.08, compared to $0.63 from the year-ago quarter. The current stock performance of Industrias Bachoco SAB shows a 52-week-high of $54.24 and a 52-week-low of $36.98. Moreover, at the end of the last trading period, the closing price was at $53.21.
For ZipRecruiter Inc (NYSE:ZIP), Raymond James downgraded the previous rating of Strong Buy to Outperform. In the fourth quarter, ZipRecruiter showed an EPS of $0.17, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $25.00 and a 52-week-low of $13.78. At the end of the last trading period, ZipRecruiter closed at $23.25.
For AbbVie Inc (NYSE:ABBV), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the fourth quarter, AbbVie showed an EPS of $3.60, compared to $3.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $175.91 and a 52-week-low of $134.09. AbbVie closed at $152.00 at the end of the last trading period.
According to Piper Sandler, the prior rating for Horizon Bancorp (IN) (NASDAQ:HBNC) was changed from Overweight to Neutral. Horizon Bancorp earned $0.48 in the fourth quarter, compared to $0.54 in the year-ago quarter. The stock has a 52-week-high of $20.78 and a 52-week-low of $14.45. At the end of the last trading period, Horizon Bancorp closed at $15.63.
According to Atlantic Equities, the prior rating for American International Group Inc (NYSE:AIG) was changed from Overweight to Neutral. For the fourth quarter, American Intl Gr had an EPS of $1.36, compared to year-ago quarter EPS of $1.58. The stock has a 52-week-high of $65.73 and a 52-week-low of $47.05. At the end of the last trading period, American Intl Gr closed at $59.72.
See all analyst ratings downgrades.
Initiations
With a Buy rating, Lake Street initiated coverage on NeuroPace Inc (NASDAQ:NPCE). The price target seems to have been set at $10.00 for NeuroPace. In the third quarter, NeuroPace showed an EPS of $0.48, compared to $0.34 from the year-ago quarter. The current stock performance of NeuroPace shows a 52-week-high of $9.54 and a 52-week-low of $1.22. Moreover, at the end of the last trading period, the closing price was at $5.34.
Piper Sandler initiated coverage on NewtekOne Inc (NASDAQ:NEWT) with a Neutral rating. In the third quarter, NewtekOne showed an EPS of $0.62, compared to $0.56 from the year-ago quarter. The stock has a 52-week-high of $28.42 and a 52-week-low of $14.75. At the end of the last trading period, NewtekOne closed at $19.83.
With a Buy rating, Roth MKM initiated coverage on Immix Biopharma Inc (NASDAQ:IMMX). The price target seems to have been set at $14.00 for Immix Biopharma. At the moment, the stock has a 52-week-high of $3.90 and a 52-week-low of $0.68. Immix Biopharma closed at $2.07 at the end of the last trading period.
For Ryvyl Inc (NASDAQ:RVYL), HC Wainwright & Co. initiated coverage, by setting the current rating at Neutral. For the third quarter, Ryvyl had an EPS of $0.00, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $1.01 and a 52-week-low of $0.40. At the end of the last trading period, Ryvyl closed at $0.49.
With an Outperform rating, Credit Suisse initiated coverage on Olema Pharmaceuticals inc (NASDAQ:OLMA). The price target seems to have been set at $12.00 for Olema Pharmaceuticals. Olema Pharmaceuticals earned $0.57 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $6.08 and a 52-week-low of $2.00. At the end of the last trading period, Olema Pharmaceuticals closed at $4.16.
With an Outperform rating, Cowen & Co. initiated coverage on OmniAb Inc (NASDAQ:OABI). The price target seems to have been set at $10.00 for OmniAb. At the moment, the stock has a 52-week-high of $5.13 and a 52-week-low of $1.91. OmniAb closed at $3.86 at the end of the last trading period.
DA Davidson initiated coverage on Manhattan Associates Inc (NASDAQ:MANH) with a Neutral rating. The price target for Manhattan Associates is set to $145.00. In the fourth quarter, Manhattan Associates showed an EPS of $0.81, compared to $0.48 from the year-ago quarter. The current stock performance of Manhattan Associates shows a 52-week-high of $158.61 and a 52-week-low of $106.02. Moreover, at the end of the last trading period, the closing price was at $143.04.
